Lee Financial’s Pacer BioThreat Strategy ETF VIRS Stock Holding History

Lee Financial’s Portfolio VIRS Stock Details VIRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,458	Closed	-$51K	–	990
2021 Q4	$51K	Hold	1,458	–	–	0.01%	257
2021 Q3	$47K	Buy	+1,458	New	+$48.5K	0.01%	233

Other funds holding VIRS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Lee Financial's VIRS Position: Q1 2022 in Review

Lee Financial sold out of Pacer BioThreat Strategy ETF (VIRS) in Q1 2022, closing a stake of 1,458 shares — an estimated $51K sold.

Lee Financial first reported a position in VIRS in Q3 2021 and held it in 2 quarters. The position peaked at $51K in Q4 2021. 4 funds tracked by Wall St. Rank hold VIRS as of Q1 2022.

Lee Financial reported no remaining Pacer BioThreat Strategy ETF position as of Q1 2022 after selling out during the quarter.
Lee Financial sold 1,458 Pacer BioThreat Strategy ETF shares in Q1 2022, an estimated $51K.
Lee Financial first reported a position in Pacer BioThreat Strategy ETF in Q3 2021 and held it in 2 quarters.
Lee Financial's Pacer BioThreat Strategy ETF position peaked at $51K in Q4 2021.
4 funds tracked by Wall St. Rank held Pacer BioThreat Strategy ETF as of Q1 2022.

Based on Lee Financial's 13F filing for Q1 2022, filed 11 May 2022.